PHILLIP A. SHARP - 09 Feb 2022 Form 4 Insider Report for ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Role
Director
Signature
By: /s/ Mary Beth DeLena, Attorney-in-Fact For: Phillip A. Sharp
Issuer symbol
ALNY
Transactions as of
09 Feb 2022
Net transactions value
-$4,160,100
Form type
4
Filing time
11 Feb 2022, 15:04:06 UTC
Previous filing
19 Jul 2021
Next filing
20 May 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALNY Common Stock Options Exercise $339,900 +30,000 $11.33* 30,000 09 Feb 2022 Direct F1
transaction ALNY Common Stock Sale $4,500,000 -30,000 -100% $150.00 0 09 Feb 2022 Direct F1
holding ALNY Common Stock 266,899 09 Feb 2022 by Trust F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALNY Stock Option (right to buy) Options Exercise $0 -30,000 -100% $0.000000* 0 09 Feb 2022 Common Stock 30,000 $11.33 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 29, 2021. The 30,000 options exercised and sold by the reporting person were due to expire on June 21, 2022.
F2 Includes shares held by the Phillip A. Sharp Revocable Trust, of which the reporting person and his spouse are co-trustees. Also includes shares held in trust for the benefit of the reporting persons children, of which the reporting persons children and spouse are the trustees.